Vitamin D supplementation trials in MS patient cohorts have shown that high dose vitamin D elevates the proportion of IL-10 producing CD4+ T cells (130), increases levels of cell proliferation (131), and leads to a global increase in IL-10 levels in the serum of relapsing remitting MS patients (132–134). Here, CD4 is linked to myeloid sarcoma.